It aims to use real-time or near real-time health data to provide immediate analysis and feedback for epidemiological investigation of potential disease. With the controversy about New Delhi metallo-beta-lactamase-1 (NDM-1) still resisting to subside, the Indian Council of Medical Research (ICMR) has initiated a surveillance network exclusively.